July 8, 2026Open Access
View Full Paper2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Key Points
- The aim of the guidelines is to provide updated recommendations for the management of patients with valvular heart disease.
- Developed by the ACC/AHA Joint Committee on Clinical Practice Guidelines.
- Reviewed existing literature and evidence on valvular heart disease.
- Formulated evidence-based recommendations for diagnosis and treatment.
- Recommendations emphasize individualized treatment plans based on patient needs and disease severity.
- Guidelines highlight the importance of early intervention in symptomatic patients.
- New approaches to monitoring and follow-up care for patients with valvular heart disease were proposed.
Abstract
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
Expert Takes5 quotes
1/5
“There is a knowledge explosion in medicine today, which can overwhelm the clinician. This is particularly true in the area of valvular heart disease, in which multiple investigational trials are being rapidly performed and released, so that it becomes extremely difficult for an individual clinician to keep up with optimal treatments for each specific patient. The Valvular Heart Disease Guideline brings together experts in the field who review all the data and arrive at a consensus opinion for best treatment, outlined in the class recommendations.”
Rick A. Nishimura, Professor of Cardiovascular Diseases, Mayo ClinicMayo Clinicauto_pipelineView source
Cite This Study
Otto et al. (Thu,) studied this question.